Furthermore, by analyzing the data obtained from TCGA database, we discovered that the mRNA level of TRIM59 was considerably enhanced in PC samples compared with normal specimens and that PC patients with higher expression levels of TRIM59 had a worse survival outcome (Fig. 2A, B). This evidence concerns the gene TRIM59 and pachyonychia congenita.